Filing Details
- Accession Number:
- 0001562180-18-001976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-04-25 19:21:15
- Reporting Period:
- 2018-04-23
- Accepted Time:
- 2018-04-25 19:21:15
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1656328 | Sienna Biopharmaceuticals Inc. | SNNA | Pharmaceutical Preparations (2834) | 273364627 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1711463 | Todd Harris | C/O Sienna Biopharmaceuticals, Inc. 30699 Russell Ranch Road, Suite 140 Westlake Village CA 91362 | Head Of Corporate Development | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2018-04-23 | 525 | $20.00 | 571,541 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-04-24 | 150 | $20.00 | 571,391 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-04-25 | 300 | $20.00 | 571,091 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 22, 2017.